BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19070269)

  • 1. Prediction of withdrawal symptoms during opioid detoxification.
    Dijkstra BA; Krabbe PF; De Jong CA; van der Staak CP
    J Opioid Manag; 2008; 4(5):311-9. PubMed ID: 19070269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scopolamine detoxification technique for heroin dependence: a randomized trial.
    Liu S; Li L; Shen W; Shen X; Yang G; Zhou W
    CNS Drugs; 2013 Dec; 27(12):1093-102. PubMed ID: 24092568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outpatient versus inpatient opioid detoxification: a randomized controlled trial.
    Day E; Strang J
    J Subst Abuse Treat; 2011 Jan; 40(1):56-66. PubMed ID: 21036514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting outcome of inpatient detoxification of substance abusers.
    Franken IH; Hendriks VM
    Psychiatr Serv; 1999 Jun; 50(6):813-7. PubMed ID: 10375152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in Withdrawal and Craving Scores in Participants Undergoing Opioid Detoxification Utilizing Ibogaine.
    Malcolm BJ; Polanco M; Barsuglia JP
    J Psychoactive Drugs; 2018; 50(3):256-265. PubMed ID: 29608409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The acute effects of a rapid medical detoxification upon dysphoria and other psychopathology experienced by heroin abusers.
    Ness R; Handelsman L; Aronson MJ; Hershkowitz A; Kanof PD
    J Nerv Ment Dis; 1994 Jun; 182(6):353-9. PubMed ID: 8201308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized double-blind study of neuroelectric therapy in opiate and cocaine detoxification.
    Gariti P; Auriacombe M; Incmikoski R; McLellan AT; Patterson L; Dhopesh V; Mezochow J; Patterson M; O'Brien C
    J Subst Abuse; 1992; 4(3):299-308. PubMed ID: 1458046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychometric evaluation of the Dutch version of the Subjective Opiate Withdrawal Scale (SOWS).
    Dijkstra BA; Krabbe PF; Riezebos TG; van der Staak CP; De Jong CA
    Eur Addict Res; 2007; 13(2):81-8. PubMed ID: 17356279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reasons for Benzodiazepine Use Among Persons Seeking Opioid Detoxification.
    Stein MD; Kanabar M; Anderson BJ; Lembke A; Bailey GL
    J Subst Abuse Treat; 2016 Sep; 68():57-61. PubMed ID: 27431047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redefining addiction II. The meaning of addiction in our lives.
    Peele S
    J Psychedelic Drugs; 1979; 11(4):289-97. PubMed ID: 42809
    [No Abstract]   [Full Text] [Related]  

  • 11. Buprenorphine-naloxone treatment responses differ between young adults with heroin and prescription opioid use disorders.
    Romero-Gonzalez M; Shahanaghi A; DiGirolamo GJ; Gonzalez G
    Am J Addict; 2017 Dec; 26(8):838-844. PubMed ID: 29143399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Withdrawal symptoms predict prescription opioid dependence in chronic pain patients.
    Coloma-Carmona A; Carballo JL; Rodríguez-Marín J; Pérez-Carbonell A
    Drug Alcohol Depend; 2019 Feb; 195():27-32. PubMed ID: 30562677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of efficacy between buprenorphine and tramadol in the detoxification of opioid (heroin)-dependent subjects.
    Chawla JM; Pal H; Lal R; Jain R; Schooler N; Balhara YP
    J Opioid Manag; 2013; 9(1):35-41. PubMed ID: 23709302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organic mood syndrome associated with detoxification from methadone maintenance.
    Kanof PD; Aronson MJ; Ness R
    Am J Psychiatry; 1993 Mar; 150(3):423-8. PubMed ID: 8434657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a Single Lyric Analysis Intervention on Withdrawal and Craving With Inpatients on a Detoxification Unit: A Cluster-Randomized Effectiveness Study.
    Silverman MJ
    Subst Use Misuse; 2016 Jan; 51(2):241-9. PubMed ID: 26800444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pupillometric changes during gradual opiate detoxification correlate with changes in symptoms of opiate withdrawal as measured by the Weak Opiate Withdrawal Scale.
    Rosse RB; Johri S; Goel M; Rahman F; Jawor KA; Deutsch SI
    Clin Neuropharmacol; 1998; 21(5):312-5. PubMed ID: 9789712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of mianserin add-on, on the intensity of opioid withdrawal symptoms during detoxification program--a randomized, double blind, placebo controlled, prospective study.
    Herman I; Shamir D; Bar-Hamburger R; Pick CG; Schreiber S
    Addict Behav; 2005 Jul; 30(6):1154-67. PubMed ID: 15925125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is premature termination of opiate detoxification due to intensive withdrawal or craving?].
    Scherbaum N; Heppekausen K; Rist F
    Fortschr Neurol Psychiatr; 2004 Jan; 72(1):14-20. PubMed ID: 14745685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. General anaesthesia does not improve outcome in opioid antagonist detoxification treatment: a randomized controlled trial.
    De Jong CA; Laheij RJ; Krabbe PF
    Addiction; 2005 Feb; 100(2):206-15. PubMed ID: 15679750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single high-dose buprenorphine for opioid craving during withdrawal.
    Ahmadi J; Jahromi MS; Ghahremani D; London ED
    Trials; 2018 Dec; 19(1):675. PubMed ID: 30526648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.